간편결제 가능보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
근 위축성 측면 경화증 시장. 2019 년 근 위축성 측면 경화증 시장 규모는 547.20 만 달러로 추정되며 예측 기간 2022-2027 년 동안 5.8%의 CAGR로 증가합니다. 근 위축성 측면 경화증 (ALS) 또는 Lou Gehrig 's Disease는 자발적인 근육을 제어하는 책임있는 중추 신경계의 신경 세포를 손상시키는 진행성 신경 퇴행성 장애입니다
Summary
Amyotrophic Lateral Sclerosis Market. Amyotrophic Lateral Sclerosis Market size in 2019 is estimated to be $ 547.2million, growing at a CAGR of 5.8% during the forecast period 2022-2027. Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a progressive neurodegenerative disorder that damages nerve cells in the central nervous system responsible for controlling the voluntary muscles
Table of Contents
1. Amyotrophic Lateral Sclerosis Market Overview
1.1 Definitions and Scope
2. Amyotrophic Lateral Sclerosis Market Executive Summary
2.1 Market Size and Key Trends
2.2 Key trends by Drug Type
2.3 Key trends by Treatment
2.4 Key trends by Distribution Channel
2.5 Key trends by Geography
3. Amyotrophic Lateral Sclerosis Market Landscape
3.1 Market Share Analysis- Key Companies
3.2 Product Benchmarking- Key Companies
3.3 Financial Analysis - Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis
4. Amyotrophic Lateral Sclerosis Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters Five Force Model
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Powers of Customers
4.3.3 Threat of New Entrants
4.3.4 Rivalry Among Existing Players
4.3.5 Threat of Substitutes
5. Amyotrophic Lateral Sclerosis Market Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Synthetic Vitamin E Market– By Drug Type (Market Size -$Million/$Billion)
6.1 Riluzole
6.2 Nuedexta
7. Amyotrophic Lateral Sclerosis Market– By Treatment (Market Size -$Million/$Billion)
7.1 Stem Cell Therapy
7.2 Chemotherapy
7.3 Medication
8. Amyotrophic Lateral Sclerosis Market– By Distribution Channel (Market Size -$Million/$Billion)
8.1 Hospitals
8.2 Diagnostics Centers
8.3 Clinics
8.4 Retail Pharmacies
9. Amyotrophic Lateral Sclerosis Market- By Geography (Market Size -$Million/$Billion)
9.1 North America
9.1.1 U.S.
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 U.K.
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia-Pacific
9.3.1 China
9.3.2 Japan
9.3.3 South Korea
9.3.4 India
9.3.5 Australia & New Zealand
9.3.6 Rest of Asia-Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Africa
9.4.3 South America
10. Amyotrophic Lateral Sclerosis Market Entropy
11. Amyotrophic Lateral Sclerosis Market Company Analysis
11.1 Company Revenue, Products, M&A, Developments
11.2 Company 1
11.3 Company 2
11.4 Company 3
11.5 Company 4
11.6 Company 5
11.7 Company 6
11.8 Company 7
11.9 Company 8
11.10 Company 9
11.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
세금계산서 발행 문의
T. 070 8015 5940
보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
근 위축성 측면 경화증 시장. 2019 년 근 위축성 측면 경화증 시장 규모는 547.20 만 달러로 추정되며 예측 기간 2022-2027 년 동안 5.8%의 CAGR로 증가합니다. 근 위축성 측면 경화증 (ALS) 또는 Lou Gehrig 's Disease는 자발적인 근육을 제어하는 책임있는 중추 신경계의 신경 세포를 손상시키는 진행성 신경 퇴행성 장애입니다
Summary
Amyotrophic Lateral Sclerosis Market. Amyotrophic Lateral Sclerosis Market size in 2019 is estimated to be $ 547.2million, growing at a CAGR of 5.8% during the forecast period 2022-2027. Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a progressive neurodegenerative disorder that damages nerve cells in the central nervous system responsible for controlling the voluntary muscles
Table of Contents
1. Amyotrophic Lateral Sclerosis Market Overview
1.1 Definitions and Scope
2. Amyotrophic Lateral Sclerosis Market Executive Summary
2.1 Market Size and Key Trends
2.2 Key trends by Drug Type
2.3 Key trends by Treatment
2.4 Key trends by Distribution Channel
2.5 Key trends by Geography
3. Amyotrophic Lateral Sclerosis Market Landscape
3.1 Market Share Analysis- Key Companies
3.2 Product Benchmarking- Key Companies
3.3 Financial Analysis - Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis
4. Amyotrophic Lateral Sclerosis Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters Five Force Model
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Powers of Customers
4.3.3 Threat of New Entrants
4.3.4 Rivalry Among Existing Players
4.3.5 Threat of Substitutes
5. Amyotrophic Lateral Sclerosis Market Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Synthetic Vitamin E Market– By Drug Type (Market Size -$Million/$Billion)
6.1 Riluzole
6.2 Nuedexta
7. Amyotrophic Lateral Sclerosis Market– By Treatment (Market Size -$Million/$Billion)
7.1 Stem Cell Therapy
7.2 Chemotherapy
7.3 Medication
8. Amyotrophic Lateral Sclerosis Market– By Distribution Channel (Market Size -$Million/$Billion)
8.1 Hospitals
8.2 Diagnostics Centers
8.3 Clinics
8.4 Retail Pharmacies
9. Amyotrophic Lateral Sclerosis Market- By Geography (Market Size -$Million/$Billion)
9.1 North America
9.1.1 U.S.
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 U.K.
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia-Pacific
9.3.1 China
9.3.2 Japan
9.3.3 South Korea
9.3.4 India
9.3.5 Australia & New Zealand
9.3.6 Rest of Asia-Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Africa
9.4.3 South America
10. Amyotrophic Lateral Sclerosis Market Entropy
11. Amyotrophic Lateral Sclerosis Market Company Analysis
11.1 Company Revenue, Products, M&A, Developments
11.2 Company 1
11.3 Company 2
11.4 Company 3
11.5 Company 4
11.6 Company 5
11.7 Company 6
11.8 Company 7
11.9 Company 8
11.10 Company 9
11.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
